Nanocarry therapeutics ltd
General Data
Reg Number
516332640
Sector
Biomed
Established
2020
No. of Employees
10
Stage
R&D
Additional Funding
1
Description
Biopharma company developing therapeutics for neuro-oncology, based on a bioengineered particle platform that penetrates the blood-brain-barrier. AxS007, its lead product, carries antibodies for the treatment of breast cancer brain metastases.
Technology
Nanocarry is developing a new class of brain therapeutics, which combines biological approaches with nanoparticles to allow biologics to cross the blood brain barrier, creating therapeutics for neuro-oncology indications and CNS diseases.
Targeted Customers
Hospitals, People with neurological disorders, Oncologists.
Management personnel
Revital Mandil-Levin - CEO & Co-Founder
Oshra Betzer - COO & CTO & Co-Founder
Winning details
Route name
Winning year
R&D Program second/third year request for Corporate Startup Corporate
R&D Program second/third year request for Corporate Startup Corporate
2023
Startup Fund
Startup Fund
2024